Skip to Content

Atomoxetine Accord 10/18/25/40/60/80/100 mg Hard Capsules – PA2315/019/001-007

09/07/2024
Medicines for human use Recall

We wish to advise you that all in-date batches of the above products are being recalled with immediate effect. 

This recall is to pharmacy level.

The reason for the recall is out of specification assay results. 

Wholesalers can download a copy of the wholesaler recall letter in the documents attached to this notice.
Pharmacists can download a copy of the pharmacy recall letter in the documents attached to this notice.

Product information

Authorisation holder
Accord Healthcare Ireland Ltd
Authorisation number
PA2315/019/001
PA2315/019/002
PA2315/019/003
PA2315/019/004
PA2315/019/005
PA2315/019/006
PA2315/019/007
Serial or batch number and expiry date
All in-date batches
Human or veterinary medicine
Human
Target audience
Pharmacists and Wholesalers
Recall level
Pharmacy level

Actions to be taken

Information for pharmacists:

Pharmacists are requested to carry out the following actions:

  1. Immediately identify and quarantine any units of these products which you have in your pharmacy. For hospital pharmacists, this includes stock on wards, in clinics and at any other relevant locations within your hospital. 
  2. Return quarantined units to your supplier, indicating that they are being returned as a result of this recall action.
  3. If you have supplied units of these products to any other pharmacy, clinic or other such establishment, please forward a copy of the recall letter to them, and request they quarantine and return any unused units to you.

Information for patients:

If you have any queries, please contact your prescriber or pharmacist.

Adverse reactions should be reported to Accord (medinfo@accord-healthcare.com) and to the HPRA (medsafety@hpra.ie).

Documents

Opens in new window Atomoxetine -Pharmacy recall letter -09 July 2024 PDF : 350KB | 09/07/2024 Opens in new window Atomoxetine -Wholesale recall letter -09 July 2024 PDF : 350KB | 09/07/2024